SuperworthJade Biosciences shares outstanding JBIO
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 61.1M
- On a year earlier
- +114.7%
- more shares
Jade Biosciences had 61.1M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 114.7% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 53.7M | +6474% |
| FY2024 | 817.5K | +3% |
| FY2023 | 791.3K | +13% |
| FY2022 | 703.2K | +0% |
| FY2021 | 700K | +9979% |
| FY2020 | 6.9K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 61.1M | +115% | |
| Q1 FY26 | 57.8M | +1731% | |
| Q4 FY25 | 53.7M | +6474% | |
| Q3 FY25 | 39.6M | +1154% | |
| Q2 FY25 | 28.4M | +3360% | |
| Q1 FY25 | 3.2M | +297% | |
| Q4 FY24 | 817.5K | +3% | |
| Q3 FY24 | 3.2M | +300% | |
| Q2 FY24 | 821.6K | +14% | |
| Q1 FY24 | 794.2K | +12% | |
| Q4 FY23 | 791.3K | +13% | |
| Q3 FY23 | 789.7K | +13% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Jade Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.